Chapel Hill, N.C. — Chapel Hill development-stage pharmaceutical company NeuroGate Therapeutics, a spinout from the University of North Carolina at Chapel Hill, has been awarded a $25,000 grant from the Epilepsy Foundation to help the company develop its unique treatment for the debilitating condition....